Multi-Year Studies from Sun Nuclear's SunCHECK™ Platform Customer Advisory Board to be Presented at ESTRO 2021
Retrieved on:
Wednesday, August 25, 2021
MELBOURNE, Fla., Aug. 25, 2021 /PRNewswire/ -- Sun Nuclear Corporation (Sun Nuclear) announced today that as part of the ESTRO 2021 Congress, held August 27 – 31 in Madrid, Spain, and streaming online, the company will host well-published clinicians in its booth and at a satellite symposium. Featured in the ESTRO scientific program, three members of the Sun Nuclear SunCHECK™ Platform Customer Advisory Board will present on breakthrough findings from their use of SunCHECK software for independent, automated Machine QA and Patient QA, featuring in-vivo dosimetry.
Key Points:
- Featured in the ESTRO scientific program, three members of the Sun Nuclear SunCHECK Platform Customer Advisory Board will present on breakthrough findings from their use of SunCHECK software for independent, automated Machine QA and Patient QA, featuring in-vivo dosimetry.
- A main interest among the SunCHECK Customer Advisory Board is implementing in-vivo dosimetry with SunCHECK software to efficiently uncover errors during the radiation therapy treatment course.
- Nuria Jornet, Ph.D., a medical physicist with Hospital de la Santa Creu i Sant Pau (Barcelona, Spain) and member of the SunCHECK Customer Advisory Board, will also present her department's experience with SunCHECK Platform during Sun Nuclear's Lunch Symposium.
- "We've built and continue to enhance the independent SunCHECK Platform to help radiotherapy teams standardize, streamline and automate their QA," notes Andy Fuller, Director of Product Management, SunCHECK.